K. Beckmann MSc

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Whereas the effect of interferons (IFNs) on magnetic resonance imaging (MRI) outcome measures in patients with multiple sclerosis (MS) has been convincingly shown, little work has been done to define the between–patient heterogeneity of treatment response. Our aim was to assess the distribution of the effect of IFNβ– 1b in terms of reduction of active T2(More)
  • 1